| Literature DB >> 33946437 |
Carmen Sánchez-Urbano1, María J Pino1, Carlos Herruzo1.
Abstract
Type 1 diabetes (Dm1) is a chronic endocrine and metabolic disease that affects the whole person and requires active, decisive treatment. However, personality traits may influence a patient's adherence to treatment guidelines. The objective of this work is firstly to identify the 3 Asendorpf personality prototypes (resilient, undercontrolled and overcontrolled) in a sample of Dm1 individuals and determine whether there are any differences in comparison with a control sample; and, secondly, to study their association with adherence to self-care guidelines using both physiological indicators (HbA1C) and self-report measures. To achieve these objectives, a descriptive cross-sectional study was carried out. The sample comprised 294 participants, of whom 104 were people with Dm1 and 190 were controls. The participants, aged between 14 and 34 years, were classified by their scores in NEO-FFI-R, according to the personality characteristics inherent to Asendorpf's prototypes. Asendorpf's 3 prototypical personality patterns were found both in the group of people with Dm1 and in the control sample. These patterns showed different degrees of association with adherence to self-care guidelines for this disease and with psychological health factors. Importance should therefore be attached to the personality traits and Asendorpf prototypes of people with Dm1 when proposing interventions to address medical, psychological, and behavioral aspects.Entities:
Keywords: adherence; personality prototypes; type 1 diabetes
Year: 2021 PMID: 33946437 PMCID: PMC8124777 DOI: 10.3390/ijerph18094818
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Prototype percentages in Dm1 and Control samples.
| Group | Not Classified (%) | Resilient (%) | Overcontrolled (%) | Undercontrolled (%) |
|---|---|---|---|---|
| Dm1 | 51.90 | 24.00 | 6.70 | 17.30 |
| Control | 50.00 | 14.70 | 12.10 | 23.20 |
X2 = 6.268, p = 0.099.
Adherence data.
| Adherence Data | Resilient | Overcontrolled | Undercontrolled | F |
| ŋ2 |
|---|---|---|---|---|---|---|
| HbA1c | 7.62 ± 1.16 | 6.68 ± 1.43 | 7.25 ± 0.98 | 1.484 | 0.240 | |
| Perceived Adherence | 0.99 ± 0.90 | 1.61 ± 0.87 | 1.74 ± 0.97 | 3.664 | 0.033 | 0.137 |
| Estimation error | 1.70 ± 1.45 | −0.32 ± 1.74 | 0.42 ± 1.54 | 4.985 | 0.012 | 0.222 |
HbA1C = Glycosylated hemoglobin.
CORE-OM questionnaire scores by Asendorpf personality prototype patterns.
| Scale | Group | Resilient | Overcontrolled | Undercontrolled | F |
| ŋ2 |
|---|---|---|---|---|---|---|---|
| Total CORE | Dm | 1.12 ± 0.25 | 1.73 ± 0.80 | 1.36 ± 0.44 | 5.227 | 0.009 | 0.196 |
| C | 1.28 ± 0.36 | 1.58 ± 0.41 | 1.41 ± 0.39 | 4.053 | 0.021 | 0.082 | |
| CORE W | Dm | 1.93 ± 0.34 | 2.46 ± 0.83 | 1.88 ± 0.77 | 2.545 | 0.090 | 0.102 |
| C | 2.21 ± 0.67 | 1.90 ± 0.52 | 2.07 ± 0.64 | 1.496 | 0.230 | ||
| CORE P | Dm | 0.73 ± 0.49 | 1.68 ± 0.86 | 1.24 ± 0.70 | 7.354 | 0.002 | 0.246 |
| C | 0.92 ± 0.54 | 1.82 ± 0.73 | 1.21 ± 0.69 | 12.095 | 0.000 | 0.210 | |
| CORE PAnxiety | Dm | 0.92 ± 0.69 | 1.71 ± 0.88 | 1.32 ± 0.79 | 3.508 | 0.038 | 0.135 |
| C | 0.90 ± 0.59 | 1.87 ± 0.71 | 1.31 ± 0.83 | 10.972 | 0.000 | 0.194 | |
| CORE PDepressed | Dm | 0.47 ± 0.57 | 1.64 ± 0.96 | 0.99 ± 0.62 | 9.628 | 0.000 | 0.300 |
| C | 0.73 ± 0.55 | 1.76 ± 1.08 | 1.01 ± 0.70 | 11.864 | 0.000 | 0.207 | |
| CORE PTrauma | Dm | 1.00 ± 0.77 | 2.00 ± 0.82 | 1.59 ± 1.15 | 3.998 | 0.025 | 0.151 |
| C | 1.38 ± 1.04 | 1.85 ± 0.79 | 1.42 ± 0.96 | 1.951 | 0.148 | ||
| CORE PP.S. | Dm | 0.63 ± 0.61 | 1.36 ± 1.07 | 1.12 ± 0.91 | 3.194 | 0.050 | 0.124 |
| C | 0.89 ± 0.79 | 1.80 ± 0.91 | 1.16 ± 0.99 | 6.567 | 0.002 | 0.126 | |
| CORE F | Dm | 1.84 ± 0.32 | 2.04 ± 0.51 | 1.72 ± 0.55 | 1.267 | 0.292 | |
| C | 1.94 ± 0.42 | 1.87 ± 0.34 | 1.90 ± 0.29 | 0.249 | 0.780 | 0.005 | |
| CORE FClose | Dm | 3.11 ± 0.59 | 2.39 ± 0.67 | 2.62 ± 0.54 | 5.925 | 0.005 | 0.208 |
| C | 2.95 ± 0.84 | 2.16 ± 0.60 | 2.65 ± 0.69 | 9.600 | 0.001 | 0.143 | |
| CORE FSocial | Dm | 2.04 ± 0.48 | 2.50 ± 0.75 | 1.94 ± 0.67 | 2.275 | 0.114 | |
| C | 2.05 ± 0.50 | 2.16 ± 0.51 | 2.04 ± 0.39 | 0.575 | 0.564 | ||
| CORE FGeneral | Dm | 0.40 ± 0.44 | 1.21 ± 0.57 | 0.87 ± 0.68 | 7.389 | 0.002 | 0.247 |
| C | 0.68 ± 0.62 | 1.28 ± 0.73 | 1.01 ± 0.66 | 5.293 | 0.007 | 0.104 | |
| CORE R | Dm | 0.02 ± 0.07 | 0.76 ± 1.05 | 0.36 ± 0.49 | 7.042 | 0.002 | 0.238 |
| C | 0.11 ± 0.22 | 0.34 ± 0.42 | 0.40 ± 0.61 | 3.284 | 0.042 | 0.067 | |
| CORE RSelf. | Dm | 0.02 ± 0.10 | 0.79 ± 1.07 | 0.19 ± 0.50 | 6.422 | 0.004 | 0.222 |
| C | 0.03 ± 0.10 | 0.35 ± 0.59 | 0.30 ± 0.59 | 3.381 | 0.038 | 0.069 | |
| CORE ROthers | Dm | 0.02 ± 0.10 | 0.71 ± 1.07 | 0.71 ± 0.61 | 9.670 | 0.000 | 0.301 |
| C | 0.25 ± 0.57 | 0.30 ± 0.39 | 0.62 ± 0.82 | 3.139 | 0.048 | 0.065 |
HbA1C = Glycosylated hemoglobin; Dm = Diabetes; C=Control; W = Subjective well-being; P = Psychological Problems; F = Functioning; R = Risk; P.S. = Physical symptoms; R. Self = Risk to self-harm; R. Others = Risk to harm to others; ŋ2 = Magnitude of the ANOVA effect.